BICO.ST Stock - BICO Group AB (publ)
Unlock GoAI Insights for BICO.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.95B | $2.01B | $2.24B | $1.26B | $176.79M |
| Gross Profit | $1.01B | $993.20M | $1.83B | $1.00B | $163.62M |
| Gross Margin | 51.8% | 49.4% | 81.7% | 79.7% | 92.5% |
| Operating Income | $-289,100,000 | $-566,700,000 | $-618,300,000 | $-160,000,000 | $-66,088,000 |
| Net Income | $-5,500,000 | $-1,172,700,000 | $-835,700,000 | $-229,200,000 | $-61,888,000 |
| Net Margin | -0.3% | -58.3% | -37.3% | -18.2% | -35.0% |
| EPS | $-0.08 | $-16.62 | $-12.99 | $-4.00 | $-1.47 |
BICO Group AB (publ) operates as a bio convergence company in North America, Europe, Asia, and internationally. It operates through two segments, Laboratory Solutions and Bioautomation. The Laboratory Solutions segment offers 3D bioprinters, hybrid microscopes, single-cell dispensing instruments, and liquid handling instruments, as well as services and related consumables, such as bioinks, reagents, microscope lenses, software, printheads, and 3D reconstructed human tissues for applications in regulatory testing. This segment also offers services in 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology to pharmaceutical and biotechnology companies. The Bioautomation segment offers products in precision dispensing and biosensor technology to the industrial customer; and diagnostics automation and advanced robotics solutions for the medical and diagnostic industries. In addition, it offers core industrial ecosystem, tissue engineering, multi-omics, cell line development, and diagnostics solutions. It primarily serves medical, pharmaceutical, and cosmetic industries. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was founded in 2016 and is based in Gothenburg, Sweden.
Visit WebsiteEarnings History & Surprises
BICO.STEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 27, 2026 | — | — | — | — |
Q1 2026 | Feb 10, 2026 | — | — | — | — |
Q4 2025 | Nov 4, 2025 | $-1.02 | $-8.66 | -746.7% | ✗ MISS |
Q3 2025 | Aug 19, 2025 | $-1.20 | $-2.50 | -108.3% | ✗ MISS |
Q2 2025 | Apr 29, 2025 | $-1.23 | $-3.32 | -169.9% | ✗ MISS |
Q1 2025 | Feb 19, 2025 | $-0.35 | $4.74 | +1454.3% | ✓ BEAT |
Q4 2024 | Nov 13, 2024 | $-0.43 | $-3.49 | -711.6% | ✗ MISS |
Q3 2024 | Aug 20, 2024 | $-0.95 | $-1.10 | -15.8% | ✗ MISS |
Q2 2024 | May 7, 2024 | $-0.71 | $-0.40 | +43.7% | ✓ BEAT |
Q1 2024 | Feb 20, 2024 | $-0.31 | $-12.70 | -3996.8% | ✗ MISS |
Q4 2023 | Nov 14, 2023 | $-0.78 | $-1.00 | -28.2% | ✗ MISS |
Q3 2023 | Aug 22, 2023 | $-1.18 | $-12.73 | -978.8% | ✗ MISS |
Q2 2023 | May 4, 2023 | $-1.43 | $-1.67 | -16.8% | ✗ MISS |
Q1 2023 | Feb 22, 2023 | $-0.32 | $-13.73 | -4190.6% | ✗ MISS |
Q4 2022 | Nov 9, 2022 | $-1.77 | $1.04 | +158.8% | ✓ BEAT |
Q3 2022 | Aug 24, 2022 | $-1.44 | $0.68 | +147.2% | ✓ BEAT |
Q2 2022 | May 18, 2022 | $-1.63 | $-0.68 | +58.3% | ✓ BEAT |
Q1 2022 | Feb 23, 2022 | $-0.82 | $-0.41 | +50.0% | ✓ BEAT |
Q4 2021 | Nov 10, 2021 | $-1.44 | $-1.81 | -25.7% | ✗ MISS |
Q3 2021 | Aug 18, 2021 | $-0.64 | $-0.89 | -39.1% | ✗ MISS |
Latest News
Frequently Asked Questions about BICO.ST
What is BICO.ST's current stock price?
What is the analyst price target for BICO.ST?
What sector is BICO Group AB (publ) in?
What is BICO.ST's market cap?
Does BICO.ST pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to BICO.ST for comparison